Senate Passes $480 Billion COVID-19 Package To Expand Testing, Help Small Businesses And Hospitals
The Senate passed an approximately $480 billion relief package, comprising billions of dollars in the form of funding for small businesses affected by the coronavirus pandemic, as well as other priorities like funding for hospitals and expanded COVID-19 testing, Tuesday (April 21).
The package was passed by the Senate via a voice vote, allowing most senators to avoid visiting Washington, DC, during the pandemic. The bill is slated to go to the house, which is likely to vote on the package on Thursday.
The bill bears a steep price tag of $484 billion, which consist of Washington's latest remarkable effort to restore the economy in the wake of the $2 trillion rescue package, the 192 billion relief measure, along with another $8.3 billion plan, which was approved by Congress last month. Democratic leaders are currently planning to come up with another enormous rescue bill.
A copy of the 25 pages long legislative text obtained by CNN, featuring an extensive analysis suggests the deal will permit the Paycheck Protection Program to spend $310 billion. The program was created to help small businesses that are struggling with the economic freeze due to the pandemic.
Earlier this month, funding for the program tapered off, causing panic in the small business community. The deal will also dol out $75 billion for those working in hospitals and other health care providers affected by the pandemic as coronavirus expenses and lost revenue, in addition to a $25 billion for expanding COVID-19 testing.
The Senate assembled at 4 PM and before the vote, some senators Democrats and Republicans debated the deal, following in the footsteps of Republican Sen. Rand Paul who voiced opposition. The coronavirus bailout has already set the country back more than $2 trillion; he pointed out, adding that continuing on this course isn't plausible.
Moreover, Sen. Rand Paul noted that no amount of bailout dollars will revive the economy since it is affected by quarantine. There's no dearth of money, he noted, but a lack of commerce, meaning, this crisis will not end until the economy re-opens.
$25 billion, according to the analysis, will be spent on necessary expenses such as administering, purchasing, manufacturing, validating, developing, researching and expanding capacity for COVID-19 tests. About $11 billion of the total amount allocated for testing will be given to states and localities to analyze COVID-19 tests.
The rest of the money will be given to other sections including federal agencies to give away to labs and spend on new technologies.